Purchase order 4800163071

The University of Nebraska Medical Center (UNMC) in Omaha, Nebraska awarded a purchase order (PO) to Sigma Aldrich Inc. on December 4, 2025, for the procurement of three pharmaceutical materials. The contract, valued at $403.10, covers the acquisition of 1 each of Emtricitabine (priced at $104.00), Tenofovir (priced at $212.00), and Raltegravir (priced at $87.10). The delivery destination is specified as the Durham Research Center, located at 550 S 45 St, Omaha, NE 68105, with the specific unloading point identified as DRC2 Room 1048.

The contract's period of performance is brief, spanning from the award date of December 4, 2025, to the delivery completion date of December 11, 2025. The purchase order is structured with Net 30 payment terms and is F.O.B. destination with freight prepaid. The transaction is tax-exempt under number 05-8905401, and the terms are governed by the University of Nebraska's Standard Terms of Purchase. The pharmaceutical materials appear to be research-oriented, suggesting potential use in medical or scientific investigation at the UNMC Durham Research Center.